Increased Precautions We're Taking in Response to COVID-19

LAST UPDATED ON 12/17/2020

As updates on the impact of the coronavirus continue to be released, we want to take a moment to inform you of the heightened preventative measures we have put in place at Duffy's Napa Valley Rehab to keep our patients, their families, and our employees safe. All efforts are guided by and in adherence to the recommendations distributed by the CDC.

Please note that for the safety of our patients, their families, and our staff, on-site visitation is no longer allowed at Duffy's Napa Valley Rehab.

  • This restriction has been implemented in compliance with updated corporate and state regulations to further reduce the risks associated with COVID-19.
  • Options for telehealth visitation are continuously evaluated so that our patients can remain connected to their loved ones.
  • Alternate methods of communication for other services may be offered when deemed clinically appropriate.

For specific information regarding these changes and limitations, please contact us directly.

CDC updates are consistently monitored to ensure that all guidance followed is based on the latest information released.

  • All staff has received infection prevention and control training.
  • Thorough disinfection and hygiene guidance has been provided.
  • Patient care supplies such as masks and hand sanitizer are being monitored and utilized.
  • Temperature and symptom screening protocols are in place for all patients and staff.
  • Social distancing strategies have been implemented to ensure that patients and staff maintain proper distance from one another at all times.
  • Cleaning service contracts have been reviewed for additional support.
  • Personal protective equipment items are routinely checked to ensure proper and secure storage.
  • CDC informational posters are on display to provide important reminders on proper infection prevention procedures.
  • We are in communication with our local health department to receive important community-specific updates.

The safety of our patients, their families, and our employees is our top priority, and we will remain steadfast in our efforts to reduce any risk associated with COVID-19.

The CDC has provided a list of easy tips that can help prevent the spread of the coronavirus.

  • Avoid close contact with people who are sick.
  • Cover your cough or sneeze with a tissue and then immediately dispose of the tissue.
  • Avoid touching your eyes, nose, and mouth.
  • Clean and disinfect objects and surfaces that are frequently touched.
  • Wash your hands often with soap and water for at least 20 seconds.
  • Stay home when you are sick, except to get medical care.

For detailed information on COVID-19, please visit


Buprenorphine Prescriptions Tripled to Fight Opioid Epidemic

The abuse of opioids has become a prevalent problem throughout the United States. In fact, many consider this form of substance abuse to be an epidemic, as it has caused devastation in the lives of countless individuals, and yet appears to be continuously growing in prevalence.

It has been estimated that 80 people die from overdoses on opioid-based substances, which includes prescription painkillers and heroin, every day in the United States. This is the equivalent to just under 29,000 deaths related to opioid overdoses each year. Astoundingly, the number of deaths that result from drug overdoses are now even higher than those that result from automobile accidents.

The state of this epidemic has prompted the U.S. government to take action in an attempt to combat the destructive nature of this problem.

In early July 2016, the government expanded access to drugs that are used to treat opioid abuse and addiction. One such drug is buprenorphine, which is a mixed partial opioid agonist medication that is used to help treat opioid addiction by reducing or eliminating the withdrawal symptoms that would typically arise when a person attempts to stop using these types of substances.

Additionally, buprenorphine can decrease cravings, block the effects of other opioids, and ultimately help individuals achieve success in overcoming their addictions. Individuals who do not have access to medications like buprenorphine are much more likely to experience relapses should they attempt to discontinue their use.

Previously, doctors were limited in the amount of individuals for whom they could prescribe buprenorphine, maxing out at 100 people per physician. With this new initiative, however, those doctors will be able to obtain a waiver that allows them to prescribe the medication for as many as 275 people. In order to receive this waiver, prescribing physicians must obtain additional credentialing from a medical board or professional society, while also practicing in a qualified treatment setting.

By increasing the cap on the amount of people for whom doctors can prescribe buprenorphine, more individuals will have access to evidence-based opioid addiction treatment that can ultimately mean the difference between life and death.

At the present time, it is estimated that fewer than 32,000 physicians have authorization to prescribe buprenorphine, and only 6,000 of them are actively writing these prescriptions. By increasing the ability that doctors have to prescribing this medication, which is also sold under the brand name Suboxone, the hope is that more physicians will actively expand their practices in order to be able to offer this important treatment intervention.

In addition to the increase in allowances for access to buprenorphine, President Barrack Obama has called for increased funding in the amount of $1.1 billion in order to provide individuals with the ability to receive treatment wherever they reside, further enhancing the likelihood that people will take advantage of the treatment available to them.

By taking these steps, the government is not only raising awareness of the opioid epidemic, but is also providing individuals who are trapped in the insidious pattern of abusing opioids with tangible means of overcoming their addictions.